WebThe Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cytokinetics Inc’s P/E ratio is -8.23. Web2 days ago · The Cytokinetics stock price fell by -3.54% on the last day (Wednesday, 12th Apr 2024) from $35.30 to $34.05. During the last trading day the stock fluctuated 5.99% from a day low at $33.88 to a day high of $35.91. The price has been going up and down for this period, and there has been a -2.66% loss for the last 2 weeks.
Analysts Have Conflicting Sentiments on These Healthcare …
Web18 hours ago · The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator ... WebMar 29, 2024 · Price To Cash Flow (Per Share TTM) 0.00. Total Debt/Total Equity (Quarterly) 0.00. Long Term Debt/Equity (Quarterly) ... Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is ... how many sailors died on the bismarck
STOCK QUOTE Cytokinetics, Inc.
WebApr 6, 2024 · Buy Cytokinetics Inc Shares from India at $36.17 (0 Commission) today. Start investing in Cytokinetics Inc stocks from India now with fractional investing only on INDmoneyapp WebFeb 28, 2024 · In fact, the Most Accurate Estimate for the current quarter is currently at a loss of $1.18 per share for CYTK, compared to a broader Zacks Consensus Estimate of a loss of $1.22 per share. WebMar 16, 2024 · Cytokinetics, Incorporated Common Stock (CYTK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. how many sailors died on the moskva